Global Organic Rice Proteins Industry

Global Organic Rice Proteins Industry

  • July 2020 •
  • 387 pages •
  • Report ID: 5900003 •
  • Format: PDF
Global Organic Rice Proteins Market to Reach $207.8 Million by 2027

Amid the COVID-19 crisis, the global market for Organic Rice Proteins estimated at US$67.9 Million in the year 2020, is projected to reach a revised size of US$207.8 Million by 2027, growing at a CAGR of 17.3% over the analysis period 2020-2027. Rice Protein Concentrates, one of the segments analyzed in the report, is projected to record a 19.5% CAGR and reach US$85.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Rice Protein Isolates segment is readjusted to a revised 17% CAGR for the next 7-year period.

The U.S. Market is Estimated at $18.3 Million, While China is Forecast to Grow at 22.8% CAGR

The Organic Rice Proteins market in the U.S. is estimated at US$18.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$49.9 Million by the year 2027 trailing a CAGR of 22.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.2% and 15.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.7% CAGR.

Other Types Segment to Record 14.2% CAGR

In the global Other Types segment, USA, Canada, Japan, China and Europe will drive the 13.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$12.4 Million in the year 2020 will reach a projected size of US$29.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$32.3 Million by the year 2027, while Latin America will expand at a 15.9% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 387-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,
  • AIDP, Inc.
  • Axiom Foods, Inc.
  • Bioway (Xi’an) Organic Ingredients Co., Ltd.
  • Golden Grain Group Limited
  • RIBUS, Inc.
  • RiceBran Technologies
  • Shaanxi Fuheng (Fh) Biotechnology Co., Ltd.
  • Shafi Gluco-Chem (Pvt.) Ltd.
  • The Green Labs LLC.
  • Top Health Ingredients Inc.